Sage
16 benefits mapped to clinical evidence across supplements.
Dose per serving from products
111 products in our catalogue print how much Sage a serving holds.
Most common: 100 mg to 250 mg, 34% of 111 products.
| Dose per serving | Products |
|---|---|
| 10 mg or less | 3 |
| 10 mg to 25 mg | 24 |
| 25 mg to 50 mg | 17 |
| 50 mg to 100 mg | 4 |
| 100 mg to 250 mg | 38 |
| 250 mg to 500 mg | 15 |
| 500 mg to 1 g | 8 |
| over 1 g | 2 |
Dose per serving from research
12 study groups in 9 studies say how much Sage participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 250 mg to 500 mg, 58% of 12 study groups.
| Daily dose | Study groups |
|---|---|
| 250 mg to 500 mg | 7 |
| 500 mg to 1 g | 1 |
| 1 g to 2.5 g | 1 |
| 2.5 g to 5 g | 0 |
| 5 g to 10 g | 0 |
| 10 g to 25 g | 2 |
| over 25 g | 1 |
Benefit Evidence
Research sources
Mood balance (16)
- Cognitive behavioral therapy skills via a smartphone app for subthreshold depression among adults in the community: the RESiLIENT randomized controlled trial
PubMed ID: 40269333
Smartphone CBT program reduced depressive symptoms in subthreshold depression — behavioral mood benefit.
- A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)
PubMed ID: 39829389
Pramipexole in treatment‑resistant bipolar depression showed larger reductions in depressive symptoms and higher response/remission later — relevant dopaminergic mood benefit.
- Mindfulness-based cognitive therapy versus treatment as usual after non-remission with NHS Talking Therapies high-intensity psychological therapy for depression: a UK-based clinical effectiveness and cost-effectiveness randomised, controlled, superiority trial
PubMed ID: 40379363
MBCT plus usual care produced sustained reductions in depression and anxiety — psychosocial mood support evidence.
- Home-based transcranial direct current stimulation for major depressive disorder: 6-month follow-up from randomised sham-controlled trial and open-label treatment phases
PubMed ID: 40209536
Home‑based tDCS showed durable clinical response in subset with MDD — neuromodulation mood benefit.
- Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults
PubMed ID: 20937617
Sage essential oil reduced mental fatigue and increased alertness in healthy adults—supports mood/subjective wellbeing to a moderate degree (acute single‑dose trial).
- Effectiveness of Predominantly Group Schema Therapy and Combined Individual and Group Schema Therapy for Borderline Personality Disorder: A Randomized Clinical Trial
PubMed ID: 35234828
Schema therapy RCT reduced borderline personality severity and improved functioning — psychotherapeutic mood/affect benefit relevant to mood support.
- Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery
PubMed ID: 16205785
Acute doses of dried sage leaf decreased anxiety (at 300 mg) and increased measures such as calmness/contentedness (at 600 mg) in healthy adults; supports short‑term mood effects.
- Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial
PubMed ID: 35110300
IV ketamine RCT produced rapid reductions in severe suicidal ideation and depressive symptoms — strong relevance to acute mood effects.
- Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial
PubMed ID: 35046508
Repeated ketamine infusions gave rapid antidepressant effects in veterans (antidepressant signal) — relevant to mood support.
- Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program
PubMed ID: 36191643
Brexanolone produced rapid, clinically meaningful improvements in postpartum depression and anxiety — highly relevant to mood support (pharmacologic, not Sage).
- Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials
PubMed ID: 34973081
Esketamine improved depressive symptoms and functioning in TRD; relevant to pharmacologic mood support.
- Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis
PubMed ID: 38954891
Vortioxetine analysis in post‑COVID condition showed depression reduction linked to anxiety improvement — mood‑related finding.
- Vortioxetine in children and adolescents with major depressive disorder: 6-month and 18-month open-label, flexible-dose, long-term extension studies
PubMed ID: 39240359
Open‑label vortioxetine in children/adolescents associated with symptom improvements — mood improvement but uncontrolled design.
- Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial
PubMed ID: 40601310
Esketamine produced rapid and significant antidepressant effects in TRD — strong direct evidence for mood improvement (pharmacologic).
- Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK
PubMed ID: 40113355
Quetiapine augmentation reduced long‑term depressive symptom burden more than lithium — relevant clinical mood benefit.
- Task-sharing and telemedicine delivery of psychotherapy to treat perinatal depression: a pragmatic, noninferiority randomized trial
PubMed ID: 40033113
Behavioral‑activation psychotherapy noninferior to specialists for perinatal depression/anxiety — supports mood treatment via behavioral intervention.
Oral health (10)
- The effect of sage (Salvizan gel) compared to triamcinolone acetonide on the treatment of recurrent aphthous stomatitis: a double-blinded randomized clinical trial
PubMed ID: 36934268
Randomized double-blind RCT: Salvizan (sage) gel produced faster pain relief and faster complete healing of recurrent aphthous ulcers vs topical steroid — strong direct evidence for oral health benefit.
- Clinical evaluation of the effect of a hydrogen peroxide mouth rinse, sodium bicarbonate dentifrice, and mouth moisturizer on oral health
PubMed ID: 9487836
Commercial 'Sage' dentifrice (baking-soda brand) produced ~27–30% reduction in gingival inflammation in a clinical trial.
- Chlorhexidine swabbing applications under various conditions of use in preventive oral care for persons with disabilities
PubMed ID: 9002920
Chlorhexidine swabbing (product by Sage Products) plus cleaning reduced periodontal scores in adults with disabilities.
- Oral malodor reduction by a palatal mucoadhesive tablet containing herbal formulation
PubMed ID: 18468761
Palatal tablet containing a mixed herbal formulation including sage reduced oral malodor and volatile sulfur compounds vs placebo; multi‑herb formula limits sole attribution to sage but clinical effect present.
- Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
PubMed ID: 19748859
Echinacea+sage throat spray markedly reduced sore throat pain and CRP; relevant for upper‑oral/pharyngeal health though echinacea likely contributed.
- Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus® tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external beam radiotherapy
PubMed ID: 32970162
Randomized small trial directly tested sage tea mouthwash for prevention of radiation‑induced oral mucositis and found performance similar to comparator; directly relevant to oral‑health benefit.
- Sage tea-thyme-peppermint hydrosol oral rinse reduces chemotherapy-induced oral mucositis: A randomized controlled pilot study
PubMed ID: 27515877
Randomized pilot found sage/thyme/peppermint hydrosol mouth rinse significantly reduced early chemo‑induced oral mucositis (clinically meaningful reduction on day 5); multi‑herb formula and small size limit certainty but this is direct oral‑health evidence.
- Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis
PubMed ID: 16504956
Sage throat spray provided rapid symptomatic relief in viral pharyngitis—relevant to oral/pharyngeal symptom management.
- Combined herbal preparation for topical treatment of Herpes labialis
PubMed ID: 11799306
Topical sage (and rhubarb–sage) shortened healing time for labial/oral cold sores → direct oral mucosal benefit.
- Anti-inflammatory potential of an essential oil-containing mouthwash in elderly subjects enrolled in supportive periodontal therapy: a 6-week randomised controlled clinical trial
PubMed ID: 31916036
Randomized trial of a sage-containing mouthwash showed reductions in sulcus bleeding index and plaque index within the test group, though not superior to placebo.
Focus & concentration (7)
- Aroma of Genius Essential Oil Blend Significantly Enhances Cognitive Performance and Brain Metabolism in Healthy Adults
PubMed ID: 41257537
Study showed reduced arithmetic errors (serial subtraction) and modest cognitive benefits, but immediate word recall was not improved.
- Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial
PubMed ID: 35941373
Pepinemab showed exploratory cognitive improvements and reduced caudate atrophy in Huntington’s disease — relevant to memory/focus.
- A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age
PubMed ID: 29433682
Pilot randomized, double‑blind study of a sage/rosemary/melissa extract demonstrated a large, significant improvement in delayed verbal recall in adults ≤62 (Cohen's d≈0.92) — strongest direct human evidence in this dataset for sage's cognitive/memory effects, though combined‑herb formula and small sample weaken attribution solely to sage.
- Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
PubMed ID: 36544184
Lecanemab produced substantial amyloid reduction with modeled slower clinical decline in early Alzheimer's — high relevance to memory and focus outcomes.
- The Acute and Chronic Cognitive Effects of a Sage Extract: A Randomized, Placebo Controlled Study in Healthy Humans
PubMed ID: 33466627
Primary outcomes in the RCT were improved working‑memory accuracy and increased visuospatial (Corsi) span — direct evidence for memory and focus benefits.
- Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery
PubMed ID: 16205785
Acute single doses of dried sage leaf improved multitask performance and attention in healthy volunteers (dose‑dependent); supports memory/focus benefits.
- Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults
PubMed ID: 20937617
Randomized placebo‑controlled crossover human trial with Salvia lavandulaefolia essential oil showed improvements in memory and attention (strongest direct human evidence in dataset).
Respiratory comfort (4)
- Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PubMed ID: 35151397
Casirivimab+imdevimab reduced progression/mortality in hospitalized COVID‑19 (a respiratory infectious disease) — relevant to respiratory outcomes via antibody therapy.
- Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
PubMed ID: 19748859
Echinacea+sage throat spray was non‑inferior to chlorhexidine/lidocaine for acute sore throat with large pain and CRP reductions; clinical respiratory/upper airway symptom improvement though product combined with echinacea.
- Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis
PubMed ID: 16504956
Randomized double‑blind trial: 15% sage spray reduced throat pain rapidly and was well tolerated in acute viral pharyngitis—strong symptomatic respiratory benefit (upper airway).
- Randomized controlled trial for Salvia sclarea or Lavandula angustifolia: differential effects on blood pressure in female patients with urinary incontinence undergoing urodynamic examination
PubMed ID: 23360656
Clary sage inhalation significantly reduced respiratory rate in a small human RCT—direct respiratory physiology effect.
Blood circulation (5)
- Randomized controlled trial for Salvia sclarea or Lavandula angustifolia: differential effects on blood pressure in female patients with urinary incontinence undergoing urodynamic examination
PubMed ID: 23360656
Small RCT: inhaled Salvia sclarea (clary sage) significantly lowered systolic and diastolic blood pressure versus control/lavender (direct human BP effect).
- Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity: A Randomized Clinical Trial
PubMed ID: 40465256
Simvastatin produced robust LDL reductions and CRP change — directly relevant to vascular/circulatory risk markers.
- High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial
PubMed ID: 40037382
Exercise program improved peak VO2 and reduced SBP — clear cardiovascular/circulation benefit (not sage).
- Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial
PubMed ID: 35779553
Tenecteplase vs alteplase stroke trial directly concerns cerebral reperfusion and vascular circulation outcomes — high relevance to circulation support (clinical context, not Sage).
- [Effect of point injection of red-sage-root on the hip joint function in ischemic femoral head necrosis patients]
PubMed ID: 19526810
Injecting freeze‑dried red sage root (Danshen) into points improved hip pain/function in ischemic femoral head necrosis; Danshen is classically vasoprotective/vasodilatory so results are consistent with circulation benefit, though procedure differs from oral supplement.
Inflammation (4)
- [Application of dannang recipe no. 2 in the perioperative stage of laparoscopic cholecystectomy]
PubMed ID: 19317164
Perioperative multi‑herb recipe containing red sage reduced inflammatory markers and sped GI recovery after surgery; anti‑inflammatory effect plausible though multi‑herb confounding exists.
- [Effect of point injection of red-sage-root on the hip joint function in ischemic femoral head necrosis patients]
PubMed ID: 19526810
Danshen (red sage) injections improved pain/function in ischemic bone disease; improvement is consistent with anti‑inflammatory/vascular actions of Danshen in that setting.
- Sage extract rich in phenolic diterpenes inhibits ultraviolet-induced erythema in vivo
PubMed ID: 17713873
Topical sage extract significantly reduced UV‑induced erythema comparable to 1% hydrocortisone, showing a clear anti‑inflammatory cutaneous effect.
- Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity: A Randomized Clinical Trial
PubMed ID: 40465256
Simvastatin lowered CRP versus placebo — direct inflammatory biomarker change relevant to inflammation balance.
Mental clarity (5)
- Aroma of Genius Essential Oil Blend Significantly Enhances Cognitive Performance and Brain Metabolism in Healthy Adults
PubMed ID: 41257537
Randomized inhaled‑sage aroma produced modest acute increases in alertness and reduced arithmetic errors, supporting short‑term mental clarity.
- A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age
PubMed ID: 29433682
Pilot RCT of a sage/rosemary/melissa (SRM) extract showed cognitive benefit (delayed verbal recall) in a younger subgroup — suggests clearer cognitive function but study is small and combined herbs limit attribution to sage alone.
- Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery
PubMed ID: 16205785
Single doses of dried sage leaf improved mood and (at higher dose) multitask performance in healthy adults (placebo‑controlled crossover); acute cognitive/mood benefit plausible.
- Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults
PubMed ID: 20937617
Randomized crossover single‑dose trial of Salvia lavandulaefolia essential oil improved attention and reduced mental fatigue in healthy adults (direct human cognitive evidence).
- The Acute and Chronic Cognitive Effects of a Sage Extract: A Randomized, Placebo Controlled Study in Healthy Humans
PubMed ID: 33466627
Randomized double‑blind human trial showed improved attention and working‑memory accuracy and reduced mid‑day attentional decline — consistent with enhanced mental clarity.
Metabolism (4)
- Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical trial
PubMed ID: 31987228
Human randomized, triple-blind trial: Salvia officinalis extract (330 mg/day) for 8 weeks lowered BMI and improved insulin-resistance markers (insulin, HOMA-IR) in women with PCOS — strong direct metabolic evidence in humans (modest sample/short duration).
- Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial
PubMed ID: 21506190
Double‑blind RCT of Salvia officinalis leaf extract in hyperlipidemic subjects produced a significant decrease in total cholesterol versus placebo (direct human metabolic evidence).
- Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial
PubMed ID: 35276079
Antipsychotic combination caused meaningful metabolic side effects (weight/waist increases) — directly relevant to metabolic balance (adverse example).
- Exploring the therapeutic impact of Salvia officinalis on lipid and oxidative stress markers in patients with polycystic ovary syndrome - a randomized placebo-controlled clinical trial
PubMed ID: 40141012
The PCOS RCT reported a modest but statistically significant reduction in triglycerides versus placebo, supporting a metabolic effect (small sample, short duration).
Immune support (3)
- Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PubMed ID: 35151397
Large COVID-19 monoclonal antibody RCT demonstrating improved clinical outcomes via immune-directed therapy (relevant to immune modulation though not about Sage).
- [Effect of lixu jieyu recipe in treating 75 patients with chronic fatigue syndrome]
PubMed ID: 19702080
Multi-herb decoction containing red sage root improved fatigue and altered T‑cell markers in CFS patients; immune-marker changes observed but multi-herb confounding.
- [Clinical effect of yiqi yangyin jiedu decoction in treating patients with advanced non-small cell lung cancer]
PubMed ID: 18543492
Multi-herb formula including Chinese sage increased some T‑lymphocyte measures in advanced lung cancer patients; suggests immunomodulatory effect but attribution to sage alone uncertain.
Hormone balance (4)
- Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical trial
PubMed ID: 31987228
PCOS RCT showed improved insulin resistance and BMI — PCOS is hormonally driven and metabolic improvements often reflect hormonal benefit; direct sex-hormone changes were not highlighted in the abstract, so the match is moderate-strong.
- Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: a randomized, double-blind clinical trial
PubMed ID: 22435409
Topical aromatherapy including clary sage reduced menstrual pain duration (small trial); relevant to menstrual/hormonal symptom comfort though effects were modest and not fully specific.
- [Clinical observation on ziyin tongbi decoction in treating benign prostatic hyperplasia]
PubMed ID: 19317162
Multi‑herb decoction containing red sage root improved BPH symptom scores though prostate volume unchanged; may reflect symptomatic/hormonal modulation but evidence is indirect.
- [Treatment of refractory polycystic ovary syndrome by bushen huoxue method combined with ultrasound-guided follicle aspiration]
PubMed ID: 18543483
Multi‑herb recipe including red sage root reduced testosterone and LH/LH‑FSH ratio and increased pregnancy rates in refractory PCOS; indicates hormonal effects in that multi‑herb context.
Vitality (4)
- Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery
PubMed ID: 16205785
Acute dosing raised alertness and improved performance at higher dose—indicative of short‑term increases in subjective energy/alertness.
- Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults
PubMed ID: 20937617
Sage essential oil increased alertness and reduced mental fatigue acutely, supporting subjective energy/vitality in the short term.
- High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial
PubMed ID: 40037382
High‑intensity exercise increased peak VO2 and fitness — strong direct relevance to energy and vitality.
- [Effect of lixu jieyu recipe in treating 75 patients with chronic fatigue syndrome]
PubMed ID: 19702080
Multi-herb decoction with red sage root produced greater fatigue improvement in chronic fatigue syndrome patients compared with control; supports energy/vitality benefit in that context.
Wellbeing (3)
- Role of multi-component functional foods in the complex treatment of patients with advanced breast cancer
PubMed ID: 18389773
Multi-component functional food containing sage reduced oxidative stress markers and improved some QOL subscales in advanced breast cancer patients; overall wellbeing improved but multi‑ingredient confounding exists.
- [Effect of lixu jieyu recipe in treating 75 patients with chronic fatigue syndrome]
PubMed ID: 19702080
Herbal decoction including red sage root improved fatigue scores in CFS vs control, indicating better perceived wellbeing/energy in a symptomatic population.
- High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial
PubMed ID: 40037382
Exercise improved fitness and cardiovascular risk markers — broadly relevant to overall wellbeing.
Antioxidant (3)
- Effects of dietary supplementation with sage (Salvia officinalis L.) essential oil on antioxidant status and duodenal wall integrity of laying strain growers
PubMed ID: 26812815
Chicken study: sage essential oil increased glutathione peroxidase and decreased MDA (lipid peroxidation) — supports antioxidant activity but in an avian model (indirect for humans).
- Role of multi-component functional foods in the complex treatment of patients with advanced breast cancer
PubMed ID: 18389773
Multi-component functional food containing sage reduced oxidative stress markers (FORT) in cancer patients; attribution to sage is plausible but confounded by multiple ingredients.
- Exploring the therapeutic impact of Salvia officinalis on lipid and oxidative stress markers in patients with polycystic ovary syndrome - a randomized placebo-controlled clinical trial
PubMed ID: 40141012
Randomized placebo‑controlled trial of Salvia officinalis in women with PCOS showed significant reduction in malondialdehyde (MDA) and some increase in total antioxidant capacity (TAC) — direct evidence of antioxidant activity.
Sleep quality (2)
- Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial
PubMed ID: 36098936
Daridorexant analysis in older adults showing improved night-time sleep and daytime functioning — high relevance to sleep quality outcomes.
- Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
PubMed ID: 35065036
Daridorexant RCT showed substantial objective and subjective sleep improvements — directly tests sleep quality (drug study, not Sage).
Digestive support (2)
- [Application of dannang recipe no. 2 in the perioperative stage of laparoscopic cholecystectomy]
PubMed ID: 19317164
Perioperative multi-herb recipe including red sage markedly sped recovery of gut function (earlier return of bowel sounds, flatus, defecation); strong clinical signal though formula contains multiple herbs.
- Effects of dietary supplementation with sage (Salvia officinalis L.) essential oil on antioxidant status and duodenal wall integrity of laying strain growers
PubMed ID: 26812815
Chick model showed improved gut barrier measures (TEER) with low-dose sage essential oil, indicating benefit to gut integrity (animal data).
Skin health (2)
- Sage extract rich in phenolic diterpenes inhibits ultraviolet-induced erythema in vivo
PubMed ID: 17713873
Topical sage extract reduced UV‑induced erythema in healthy volunteers, performing similarly to low‑strength hydrocortisone—direct human evidence for cutaneous anti‑inflammatory benefit.
- Combined herbal preparation for topical treatment of Herpes labialis
PubMed ID: 11799306
Randomized trial: topical sage (and rhubarb–sage combo) accelerated healing of cold sores vs placebo; direct skin/mucosal benefit.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Sage
Search all444 products whose verified label declares Sage — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.